TScan Therapeutics Inc (TCRX)
7.78
-0.23
(-2.87%)
USD |
NASDAQ |
May 09, 16:00
7.785
0.00 (0.00%)
After-Hours: 20:00
TScan Therapeutics 1 Year Total Returns (Daily): 128.8% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 09, 2024 | 128.8% |
| May 08, 2024 | 256.1% |
| May 07, 2024 | 261.2% |
| May 06, 2024 | 267.1% |
| May 03, 2024 | 273.8% |
| May 02, 2024 | 317.9% |
| May 01, 2024 | 425.6% |
| April 30, 2024 | 240.1% |
| April 29, 2024 | 238.3% |
| April 26, 2024 | 215.5% |
| April 25, 2024 | 192.8% |
| April 24, 2024 | 196.4% |
| April 23, 2024 | 193.9% |
| April 22, 2024 | 188.3% |
| April 19, 2024 | 201.8% |
| April 18, 2024 | 229.5% |
| April 17, 2024 | 234.2% |
| April 16, 2024 | 225.6% |
| April 15, 2024 | 251.1% |
| April 12, 2024 | 303.6% |
| April 11, 2024 | 286.1% |
| April 10, 2024 | 233.2% |
| April 09, 2024 | 238.6% |
| April 08, 2024 | 233.6% |
| April 05, 2024 | 232.9% |
| Date | Value |
|---|---|
| April 04, 2024 | 222.3% |
| April 03, 2024 | 219.6% |
| April 02, 2024 | 242.9% |
| April 01, 2024 | 281.4% |
| March 28, 2024 | 211.4% |
| March 27, 2024 | 244.4% |
| March 26, 2024 | 244.4% |
| March 25, 2024 | 241.8% |
| March 22, 2024 | 219.5% |
| March 21, 2024 | 173.8% |
| March 20, 2024 | 162.1% |
| March 19, 2024 | 158.1% |
| March 18, 2024 | 153.0% |
| March 15, 2024 | 171.8% |
| March 14, 2024 | 157.2% |
| March 13, 2024 | 164.2% |
| March 12, 2024 | 130.7% |
| March 11, 2024 | 123.9% |
| March 08, 2024 | 97.29% |
| March 07, 2024 | 116.4% |
| March 06, 2024 | 138.3% |
| March 05, 2024 | 125.3% |
| March 04, 2024 | 128.2% |
| March 01, 2024 | 128.6% |
| February 29, 2024 | 128.8% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-77.15%
Minimum
Aug 18 2022
425.6%
Maximum
May 01 2024
26.51%
Average
-20.20%
Median
Mar 03 2023
1 Year Total Returns (Daily) Benchmarks
| AnaptysBio Inc | 24.73% |
| CEL-SCI Corp | -41.92% |
| AIM ImmunoTech Inc | -10.90% |
| IGC Pharma Inc | 48.57% |
| NovaBay Pharmaceuticals Inc | -90.89% |